The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lemos, M. P.
Right arrow Articles by Laufer, T. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lemos, M. P.
Right arrow Articles by Laufer, T. M.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 2003, 171: 5077-5084.
Copyright © 2003 by The American Association of Immunologists

CD8{alpha}+ and CD11b+ Dendritic Cell-Restricted MHC Class II Controls Th1 CD4+ T Cell Immunity 1

Maria P. Lemos*, Lian Fan2,{dagger}, David Lo3,{dagger} and Terri M. Laufer4,*

* Department of Medicine, University of Pennsylvania, Philadelphia PA 19104; {dagger} The Scripps Research Institute, La Jolla, CA 92037

The activation, proliferation, differentiation, and trafficking of CD4 T cells is central to the development of type I immune responses. MHC class II (MHCII)-bearing dendritic cells (DCs) initiate CD4+ T cell priming, but the relative contributions of other MHCII+ APCs to the complete Th1 immune response is less clear. To address this question, we examined Th1 immunity in a mouse model in which I-A{beta}b expression was targeted specifically to the DCs of I-A{beta}b-/- mice. MHCII expression is reconstituted in CD11b+ and CD8{alpha}+ DCs, but other DC subtypes, macrophages, B cells, and parenchymal cells lack of expression of the I-A{beta}b chain. Presentation of both peptide and protein Ags by these DC subsets is sufficient for Th1 differentiation of Ag-specific CD4+ T cells in vivo. Thus, Ag-specific CD4+ T cells are primed to produce Th1 cytokines IL-2 and IFN-{gamma}. Additionally, proliferation, migration out of lymphoid organs, and the number of effector CD4+ T cells are appropriately regulated. However, class II-negative B cells cannot receive help and Ag-specific IgG is not produced, confirming the critical MHCII requirement at this stage. These findings indicate that DCs are not only key initiators of the primary response, but provide all of the necessary cognate interactions to control CD4+ T cell fate during the primary immune response.




This article has been cited by other articles:


Home page
J. Immunol.Home page
T. L. Stephen, A. Tikhonova, J. M. Riberdy, and T. M. Laufer
The Activation Threshold of CD4+ T Cells Is Defined by TCR/Peptide-MHC Class II Interactions in the Thymic Medulla
J. Immunol., November 1, 2009; 183(9): 5554 - 5562.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Niu, T. Laufer, R. J. Homer, and L. Cohn
Cutting Edge: Limiting MHC Class II Expression to Dendritic Cells Alters the Ability to Develop Th2- Dependent Allergic Airway Inflammation
J. Immunol., August 1, 2009; 183(3): 1523 - 1527.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
N. Iijima, M. M. Linehan, M. Zamora, D. Butkus, R. Dunn, M. R. Kehry, T. M. Laufer, and A. Iwasaki
Dendritic cells and B cells maximize mucosal Th1 memory response to herpes simplex virus
J. Exp. Med., December 22, 2008; 205(13): 3041 - 3052.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
T. M Strutt, J. Uzonna, K. K McKinstry, and P. A Bretscher
Activation of thymic T cells by MHC alloantigen requires syngeneic, activated CD4+ T cells and B cells as APC
Int. Immunol., May 1, 2006; 18(5): 719 - 728.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M. P. Lemos, F. Esquivel, P. Scott, and T. M. Laufer
MHC Class II Expression Restricted to CD8{alpha}+ and CD11b+ Dendritic Cells Is Sufficient for Control of Leishmania major
J. Exp. Med., March 1, 2004; 199(5): 725 - 730.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.